LCMS webinars focusing on LC/MS - page 136

We describe here workflows for quantitation and characterization at the intact level.

Being a reliable partner for your lab, we endeavor to continue providing you ROBUST analytical power to deliver HIGH EFFICIENCY to enhance your PRODUCTIVITY & PROFITABILITY.

We will discuss manufacturing processes to reduce impurity presence as far as possible, as well as laboratory analysis of incoming raw materials and finished product.

Our webinar on July 21st looks at how we can use high-throughput LC-MS analysis to systematically map the drug metabolizing capacity of the gut microbiota.

In this two-part webinar, hear from clinical chemistry experts Dr. Andrew Davison and Dr. Rachel Carling on why LC-MS/MS is needed to advance clinical laboratory medicine.

We will cover the fundamentals of multi reflecting Time-of-Flight (MRT) and address the most asked questions since launch!

Topic 1: Analysis of Methotrexate, Busulfan and 5FU from Plasma and Serum for Clinical Research and Topic 2: Rapid Analysis of Panels of Anti-Epileptic Drugs (AEDs) for Clinical Research.

In this webinar, a novel LC-MS/MS Q-TOF instrument (ZenoTOF 7600 system, SCIEX) equipped with a patented ion trap will be applied to the acquisition of highly modified oligonucleotides.

Herein, we described LC-SRM-MS method developed using the Vanquish Horizon UHPLC coupled to a TSQ Quantis for the detection and quantitation of 10 nitrosamines in metformin drug products.

Topic 1: Analysis of Plasma Mycophenolic Acid for Clinical Research and Topic 2: UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research.